Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

CMH Rawalpindi Intratympanic Methylprednisolone plus PRP Study

Also known as: Combination Solution, PRP + Solumedrol, Methyl Prednisone-platelet Rich Plasma Combination, Intra-Tympanic Steroid With PRP Combination, NCT06025097

Government-led study

Primary source

Sponsor / Institution

Government-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Early Phase 1

Status

Completed

Target Gene

—

Route / Mode

Intratympanic injection

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Pakistan

Population

adult, sensorineural, tinnitus

Trial IDs

Mechanism

Completed early Phase 1 government-led single-arm study of intratympanic methylprednisolone plus autologous platelet-rich plasma in sensorineural hearing loss and tinnitus of cochlear origin.

Indications

Hearing Loss Sensorineural Hearing Loss Tinnitus

Notes

Verified as a completed government-led study of an intratympanic methylprednisolone plus PRP combination. This is a study-level generic combination/procedure record, not a branded commercial program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...

IDs: NCT06025097

Open

Key Events

2023-09-01

Registry lists actual start of intratympanic methylprednisolone plus PRP study

2023-10-21

Registry lists actual completion of intratympanic methylprednisolone plus PRP study

Clinical Trials (1)